|
Delayed
London S.E.
14:38:18 16/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.2000 GBX | +8.11% |
|
+8.11% | - |
| 08-20 | Theracryf's fund raise; Potter & Moore sales struggle | AN |
| 05-14 | EARNINGS & TRADING: Nexus Infrastructure first-half loss narrows | AN |
Company Valuation: Theracryf Plc
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 28.21 | 12.65 | 12.58 | 3.919 | 6.191 | 6.817 | - |
| Change | - | -55.17% | -0.51% | -68.86% | 57.98% | 10.11% | - |
| Enterprise Value (EV) 1 | 11.85 | 1.317 | 6.354 | 1.358 | 3.34 | 4.657 | 6.113 |
| Change | - | -88.89% | 382.62% | -78.63% | 145.93% | 39.44% | 31.26% |
| P/E | -4x | -3.7x | -2.51x | -0.76x | -0.6x | -1.25x | -1.66x |
| PBR | 1.69x | 1.09x | 1.89x | 0.96x | 0.19x | 1.38x | - |
| PEG | - | 0.1x | -0.1x | 0x | 0x | 0x | 0.1x |
| Capitalization / Revenue | 103x | - | 22.9x | 7.75x | - | - | - |
| EV / Revenue | 43.3x | - | 11.6x | 2.68x | - | - | - |
| EV / EBITDA | -2.63x | -0.33x | -1.01x | -0.3x | -1.3x | -0.95x | - |
| EV / EBIT | -2.61x | -0.33x | -1x | -0.3x | -1.16x | -0.99x | -1.45x |
| EV / FCF | -2.88x | -0.34x | -1.24x | -0.35x | -1.04x | -1.24x | - |
| FCF Yield | -34.8% | -297% | -80.9% | -282% | -95.8% | -80.9% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | -0.0257 | -0.0124 | -0.0182 | -0.0146 | -0.00488 | -0.002 | -0.0015 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | 0.2738 | - | 0.5487 | 0.5059 | - | - | - |
| EBITDA 1 | -4.508 | -3.996 | -6.32 | -4.54 | -2.574 | -4.921 | - |
| EBIT 1 | -4.534 | -4.016 | -6.336 | -4.555 | -2.878 | -4.686 | -4.207 |
| Net income 1 | -3.773 | -3.433 | -5.019 | -4.007 | -2.63 | -3.379 | -3.458 |
| Net Debt 1 | -16.36 | -11.33 | -6.229 | -2.561 | -2.851 | -2.16 | -0.7039 |
| Reference price 2 | 0.102634 | 0.046008 | 0.045774 | 0.011061 | 0.002907 | 0.002495 | 0.002495 |
| Nbr of stocks (in thousands) | 274,888 | 274,888 | 274,888 | 354,288 | 2,129,622 | 2,732,297 | - |
| Announcement Date | 15/06/21 | 08/06/22 | 07/06/23 | 28/05/24 | 03/06/25 | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.25x | - | -0.95x | - | 6.82M | |
| 20.35x | 7.16x | 14.38x | 1.46% | 69.18B | |
| 31.96x | 9.24x | 44.57x | 0.04% | 62B | |
| -73.2x | 14.15x | -68.23x | -.--% | 26.19B | |
| 29.82x | 6.33x | 16.44x | -.--% | 25.75B | |
| -14.7x | 5.35x | -6.73x | -.--% | 24.29B | |
| 26.87x | 5.1x | 16.96x | -.--% | 19.84B | |
| 45.45x | 16.69x | 33.86x | 0.33% | 15.65B | |
| -14.9x | 3360.83x | -17.18x | -.--% | 13.88B | |
| 1005.79x | 35.18x | 607.6x | -.--% | 14.09B | |
| Average | 105.62x | 384.45x | 64.07x | 0.2% | 27.09B | |
| Weighted average by Cap. | 63.10x | 181.79x | 42.16x | 0.4% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- EVG Stock
- Valuation Theracryf Plc
Select your edition
All financial news and data tailored to specific country editions
